His research focuses on intracellular signaling and epigenetic regulation in neuronal and cancer cells. Prior to being at Binghamton, Dr. Chen investigated opioid receptor gene regulation and the molecular basis for targeting PI3K/Akt signaling for cancer therapy at the University of Minnesota. He earned his PhD from the Johns Hopkins University and did his postdoctoral fellowship at Harvard Medical School. He has published more than 20 papers in international peer-reviewed journals.